Ra Pharmaceuticals and the Pursuit of Peptide Drugs
March 22, 2013
March 22, 2013 | Doug Treco, president & CEO of Ra Pharmaceuticals, will be presenting “Direct Selection of Cyclomimetics from mRNA Display Libraries” at CHI’s Drug Discovery Chemistry conference in San Diego on April 17.
In this video preview with Bio-IT World editor Kevin Davies, Treco shares more about the mission of Ra Pharmacuticals, the enabling the technology platform, recent developments in constrained peptides, macrocyclics, and the company name that was immediately rejected by the investors.